0R15 8535.0 0.4118% 0R1E 7610.0 -0.5489% 0M69 18520.0801 47.1015% 0R2V 221.36 9893.6795% 0QYR 1226.0 1.5321% 0QYP 430.5 2.0142% 0RUK None None% 0RYA 1268.0 0.4754% 0RIH 157.1 0.0% 0RIH 157.1 0.0% 0R1O 186.19 9977.9432% 0R1O None None% 0QFP None None% 0M2Z 267.95 -0.5105% 0VSO 27.75 -22.0615% 0R1I None None% 0QZI 525.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 166.79 0.8309%
This report is an updated version of the report published on 22 August 2024 at 7:57 AM GMT+1.
Section 1: Company Overview and Fundamental Insights
1.1 Company Overview:
PureTech Health PLC (LSE: PRTC) listed on FTSE 250 index is a clinical stage biotherapeutics company focused on developing innovative medicines that aim to transform the lives of patients suffering from severe diseases. Kalkine’s Healthcare Report covers the Investment Highlights, Key Financial Metrics, Risks, Recent Business Updates along with the Valuation, Target Price, and Recommendation on the stock.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
UK 
AU
CA
US
NZ
Please wait processing your request...